Antilymphocyte antibody induction by combination of an S1P receptor agonist/modulator and of immunosuppressive drugs

Details for Australian Patent Application No. 2006212866 (hide)

Owner Novartis AG

Inventors Aradhye, Shreeram

Agent Davies Collison Cave

Pub. Number AU-A-2006212866

PCT Pub. Number WO2006/086361

Priority 60/651,045 08.02.05 US

Filing date 6 February 2006

Wipo publication date 17 August 2006

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

Event Publications

26 July 2007 PCT application entered the National Phase

  PCT publication WO2006/086361 Priority application(s): WO2006/086361

18 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006212868-Apparatus and method for locating defects in bone tissue

2006212864-Method and system for recognizing radio link failures associated with HSUPA and HSDPA channels